Cargando...
Intranasal oxytocin dampens cue-elicited cigarette craving in daily smokers: A pilot study
Despite moderate success with pharmacological and behavioral treatments, smoking relapse rates remain high, and many smokers report that smoking cues lead to relapse. Therefore, treatments that target cue reactivity are needed. One candidate for reducing craving is the neuropeptide oxytocin (OT). He...
Guardado en:
| Publicado en: | Behav Pharmacol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5089916/ https://ncbi.nlm.nih.gov/pubmed/27661192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FBP.0000000000000260 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|